Ascendis Pharma Aktie

Ascendis Pharma für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A14M6X / ISIN: US04351P1012

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
04.09.2024 22:48:00

Why Ascendis Pharma Stock Tumbled by 11% Today

An earnings miss and sharply reduced guidance for its ONE commercialized product doomed Ascendis Pharma (NASDAQ: ASND) to a bad Wednesday on the stock market. The biotech's shares fell by more than 11% in price after it divulged its latest set of quarterly results. By comparison, the bellwether S&P 500 index suffered a relatively modest drop of 0.2%.Ascendis, a biotech based in Denmark, took the wraps off its second quarter soon after market hours on Tuesday. The company posted revenue of slightly under 36 million euros ($40 million) for the period, a figure that was well down from the more than 47 million euros ($52 million) it earned in the same quarter of 2023. More encouragingly, Ascendis managed to narrow its net loss over that stretch of time. Its deficit was a bit more than 109 million euros ($120 million), which equates to 1.91 euros ($2.11) per share. The year-ago shortfall was almost 122 million euros ($135 million).Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Nachrichten zu Ascendis Pharma (spons. ADRs)mehr Nachrichten

Analysen zu Ascendis Pharma (spons. ADRs)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Ascendis Pharma (spons. ADRs) 138,00 22,12% Ascendis Pharma (spons. ADRs)